A world where bleeding is no longer a risk
Our mission is to save lives. We provide a safe, effective, and reliable solution to stop bleeding.
*Source: WHO 2024
Our Mission is to Save Lives
Uncontrolled bleeding continues to pose a significant global health challenge, highlighting the need for more effective solutions for rapid and dependable hemorrhage control
Hemorrhage is responsible for over 80% of operating-room deaths after major trauma.
It also accounts for the largest proportion of mortality in the first hour of trauma center care and nearly 50% of deaths in the first 24 hours.
91% of potentially survivable battlefield deaths are related to hemorrhage.
Rapid hemorrhage control is therefore a primary determinant of survivability in combat settings.
Cresilon closes the critical technology gap by delivering rapid, reliable hemostasis when every second matters. The hydrogel technology works fast with no-preparation and controls bleeding in seconds by adapting seamlessly to a wide range of wound types and geometries, ensuring consistent performance across diverse clinical scenarios.
Our Solution
Cresilon has developed the world’s first flowable hemostatic gel technology that achieves hemostasis in seconds for even the most severe hemorrhage
TRAUMAGEL®
TRAUMAGEL® is a hemostatic gel designed to control external moderate to severe bleeding in seconds for EMS Agencies, Trauma Hospitals, Military, and Law Enforcement.
Learn moreVETIGEL®
VETIGEL® is the first hemostatic gel in the veterinary market that stops bleeding in seconds. VETIGEL® has been used in 65,000 procedures across the globe.
Learn moreTestimonials
About Cresilon
Cresilon develops advanced hemostatic gel technology that controls bleeding in seconds. Founded and headquartered in Brooklyn, NY.
Our Products
Our plant-based technology has revolutionized the current standard of care by stopping traumatic and surgical bleeds in seconds without the need for manual pressure. Cresilon’s current and future product lines target veterinary, human trauma, and human surgical applications.
Our Story
Constantly experimenting with natural materials in the lab as a young adult, Joe Landolina developed an adhesive hemostatic gel composed of plant-based polymers that could support the natural clotting process.
Technology in Action
Latest News
Get the Latest from Cresilon
Stay in touch with us to get Cresilon’s latest news, investment opportunities, and product releases.